Coya Therapeutics Inc

NASDAQ:COYA

5.96

+0.18 (+3.11%)

3:52:36 PM EDT: $6.10 +0.14 (+2.35%)

Market Cap (Intraday)	102.78M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.94 Million
Adjusted EPS	-$0.41

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Coya Therapeutics Inc Stock, NASDAQ:COYA

5850 San Felipe Street, Suite 500, Houston, Texas 77057

United States of America

Phone: +1.800.587.8170

Number of Employees: 8

http://www.coyatherapeutics.com

Description

Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.